Replies to post #41750 on **TOP STOCK PICKS

[BottomBounce]

$OTIC Otonomy, Inc. engages in developing and commercializing therapeutics to address unmet medical needs in the otology market. It develops therapeutics for treatment of inner and middle ear disorders. The Company's product candidates under development includes AuriPro to treat pediatric patients with middle ear effusion; and OTO-104 for the treatment of patients with M'ni're's disease. Otonomy, Inc. is headquartered in San Diego, California.